Literature DB >> 24475780

Differences in the gut microbiota of healthy children and those with type 1 diabetes.

Erdogan Soyucen1, Aynur Gulcan, Ayse Cigdem Aktuglu-Zeybek, Hasan Onal, Ertugrul Kiykim, Ahmet Aydin.   

Abstract

BACKGROUND: Intestinal barriers, intestinal flora, and mucosal immunity are the main factors responsible for the development of various allergic and autoimmune diseases. The aim of this study was to investigate the relationship between the intestinal flora of children and the presence of type 1 diabetes, and to determine if gut microbiota could partly explain the etiology of the disease.
METHODS: Fecal flora analysis was done using quantitative cultures on selective and non-selective media with different thermal and atmospheric conditions for bacterial and fungal growth. The study group consisted of 35 patients (16 female, 19 male; mean age, 10.73 ± 4.16 years), who had been followed by the University of Istanbul, Cerrahpasa Medical Faculty, Department of Pediatrics, and were newly diagnosed with type 1 diabetes. The control group consisted of 35 healthy subjects (15 female, 20 male; mean age, 9.96 ± 4.09 years), who were randomly selected and had similar demographics.
RESULTS: Bifidobacterium colonization was lower in patients with type 1 diabetes compared to the control group, whereas Candida albicans and Enterobacteriaceae other than Echerichia coli colonization was increased.
CONCLUSION: A decrease in beneficial anaerobic bacteria levels and a concomitant increase in Enterobacteriaceae other than E. coli and C. albicans colonization may lead to a disturbance in the ecological balance of intestinal flora, which could be a triggering factor in type 1 diabetes etiology.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Keywords:  Candida albicans; autoimmune disease; gut flora; gut microbiota; type 1 diabetes mellitus

Mesh:

Year:  2014        PMID: 24475780     DOI: 10.1111/ped.12243

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  51 in total

Review 1.  Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis.

Authors:  Aaron Cohn; Anthony M Sofia; Sonia S Kupfer
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

Review 2.  Fungi in the healthy human gastrointestinal tract.

Authors:  Heather E Hallen-Adams; Mallory J Suhr
Journal:  Virulence       Date:  2016-10-13       Impact factor: 5.882

Review 3.  The hygiene hypothesis in autoimmunity: the role of pathogens and commensals.

Authors:  Jean-François Bach
Journal:  Nat Rev Immunol       Date:  2017-10-16       Impact factor: 53.106

Review 4.  Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.

Authors:  Momir Mikov; Maja Đanić; Nebojša Pavlović; Bojan Stanimirov; Svetlana Goločorbin-Kon; Karmen Stankov; Hani Al-Salami
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441

Review 5.  The gut microbiota and Type 1 Diabetes.

Authors:  Elke Gülden; F Susan Wong; Li Wen
Journal:  Clin Immunol       Date:  2015-06-04       Impact factor: 3.969

6.  Genistein prevention of hyperglycemia and improvement of glucose tolerance in adult non-obese diabetic mice are associated with alterations of gut microbiome and immune homeostasis.

Authors:  Guannan Huang; Joella Xu; Daniel E Lefever; Travis C Glenn; Tamas Nagy; Tai L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2017-04-12       Impact factor: 4.219

7.  Aberrant gut microbiota composition at the onset of type 1 diabetes in young children.

Authors:  Marcus C de Goffau; Susana Fuentes; Bartholomeus van den Bogert; Hanna Honkanen; Willem M de Vos; Gjalt W Welling; Heikki Hyöty; Hermie J M Harmsen
Journal:  Diabetologia       Date:  2014-06-15       Impact factor: 10.122

8.  Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole.

Authors:  A Serda Kantarcioglu; Nuri Kiraz; Ahmet Aydin
Journal:  Mycopathologia       Date:  2015-10-06       Impact factor: 2.574

Review 9.  Gut Microbiota Are Disease-Modifying Factors After Traumatic Spinal Cord Injury.

Authors:  Kristina A Kigerl; Klauss Mostacada; Phillip G Popovich
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 10.  Gut-Brain Interactions: Implications for a Role of the Gut Microbiota in the Treatment and Prognosis of Anorexia Nervosa and Comparison to Type I Diabetes.

Authors:  Daria Igudesman; Megan Sweeney; Ian M Carroll; Elizabeth J Mayer-Davis; Cynthia M Bulik
Journal:  Gastroenterol Clin North Am       Date:  2019-06-25       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.